University of Illinois Infectious Disease Head & Moderna COVID-19 Vaccine Principal Investigator Discusses Common Vaccination Questions

University of Illinois Infectious Disease Head & Moderna COVID-19 Vaccine Principal Investigator Discusses Common Vaccination Questions

Dr. Richard Novak, Head of the Division of Infectious Diseases At University of Illinois Health and Principal Investigator (PI) for the Moderna vaccine, recently spoke with Steve Dale hosting WGN Radio to discuss common vaccination questions associated with COVID-19.  Along with challenges associated with vaccine supply shortages, missed appointments and apprehension Dr. Novak offers a wealth of wisdom for the listener. Dr. Novak recommends ensuring people get both doses. Controlled trials are the only way that any COVID-19 treatments are considered, reports Dr. Novak.

The Head of the Division of Infectious Diseases at University of Illinois Health, Dr. Novak serves as the Director of the UIC Community Clinic Network (UCCN), a network of seven HIV community-based clinical and research sites located throughout Chicago—serving about 1,200 active patients. He served as a Principal Investigator on the Moderna Phase 3 vaccine study.

Dr. Novak, a front line worker, received the Pfizer vaccine although again he worked on the Moderna vaccine as PI. He says that Moderna is easier to distribute hence neighborhood pharmacies would be more likely to have the Moderna vaccine. The Pfizer ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee